Tapestry (NYSE: TPR), formally known as Coach, is undergoing two brand transformations. Its flagship Coach brand is seeing renewed sales with the introduction of its Signature series and Kate Spade is seeing improvements after pullbacks in promotions. Read More
Linda McDonough is a veteran hedge fund analyst who loves to break down company financial statements and identify market inefficiencies to uncover big opportunities. She believes in a boots-on-the-ground approach that includes surveying customers, interviewing company executives, or doing whatever it takes to see what others don't.
She's now brought her experience as a hedge fund analyst to subscribers of her Profit Catalyst Alert service. Her system identifies small- and mid-cap stocks that are about to move due to catalytic events that few others can identify...until it's too late. These events often times result in massive gains for her followers.
Analyst Articles
The bears reigned last week as Dollar General and Big Lots delivered poor results. New regulations benefit Chemours and more... Read More
Big Lots reported a horrible quarter this morning. It missed on all metrics and cut guidance for the year. Look for the puts to open up significantly this morning. Read More
Dollar General reported a messy quarter this morning. Sales of more profitable products failed to appear. Despite management keeping annual guidance, weak revenue and an increase in inventory is keeping a lid on the stock. Read More
Why I still like Target despite a slight miss in earnings, what's in store for Big Lots this week and truckers getting a boost. Our weekly roundup. Read More
Jazz is up almost 30% since my February 2017 recommendation. Recent commentary from the FDA regarding branded companies thwarting new generic entrants may drag the stock down. I'll look for a better entry point to re-visit this name. Read More
News Flash: Valeant, the once high-flying drug company, is changing its name! Just how important is a name-change in the fortunes of a company and what does it signify for the stock? Read More
Both the Walmart and Abbvie options trades worked out well for subscribers. A bit more on how these trade suggestions should work and what's on the calendar moving forward. Carbonite continues to deliver good news and why Air Transport Services lumbers along. Read More
Sell to close the June 15, 2018 call on Abbvie (NYSE: ABBV) with a strike price of $105 at $4.20 or higher for a swift 50% gain. Symbol (ABBV180615C105). It’s a beautiful thing when an options trade suggestion works out almost exactly as planned. Abbvie boosted investor confidence regarding… Read More
Sell Celgene as the stock has closed below its $83 stop loss limit for two consecutive days. Despite decent news, the stock continues to drop. Read More